Biotech · Private company
ReAlta Life Sciences, Inc.
Track this companyFree. Adds ReAlta Life Sciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- RLS-0071Phase 3 · Hypoxic-Ischemic EncephalopathyClinicalTrials.gov · fetched Nov 12, 2026
- RLS-0071Phase 2 · Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RLS-0071Phase 2 · Steroid Refractory GVHDClinicalTrials.gov · fetched Nov 12, 2026
- RLS-0071 10 mg/kgPhase 1 · Acute Lung InjuryClinicalTrials.gov · fetched Nov 12, 2026
- RLS-0071 40 mg/kgPhase 1 · Acute Lung InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host DiseasePHASE2 · RECRUITING · started Aug 31, 2024ClinicalTrials.gov NCT06343792 · fetched Nov 12, 2026
- Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jan 25, 2024ClinicalTrials.gov NCT06175065 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic HypothermiaPHASE2_PHASE3 · RECRUITING · started Jul 27, 2023ClinicalTrials.gov NCT05778188 · fetched Nov 12, 2026
- A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory FailurePHASE1 · WITHDRAWN · started Jan 1, 2021ClinicalTrials.gov NCT04574869 · fetched Nov 12, 2026